Close Menu
Business Voice NowBusiness Voice Now
    Facebook X (Twitter) Instagram
    Business Voice NowBusiness Voice Now
    Subscribe
    • Markets
      • IPO
      • Market News
    • Business
      • FMCG
      • Retail
      • Quick Commerce
      • Startups
    • Healthcare
    • Technology
    • Energy
    • Voices
      • Entrepreneur – CXO Stories
      • Corporate Office story
    • E Magazine
      • Year 2026
        • October 2026
        • September 2026
        • August 2026
        • July 2026
    Business Voice NowBusiness Voice Now
    Home»Business»Sankalp Life Care, Vaishali Pharma sign unique partnership agreement, a first in nutraceuticals market – Primex News Network
    Business

    Sankalp Life Care, Vaishali Pharma sign unique partnership agreement, a first in nutraceuticals market – Primex News Network

    By April 20, 2022No Comments3 Mins Read
    Share Facebook Twitter Pinterest LinkedIn Tumblr Email
    Follow Us
    Google News Flipboard Threads
    Share
    Facebook Twitter LinkedIn Pinterest Email

    As per an agreement signed between the two companies, Vaishali Pharma will take over the domestic and international marketing operations of Sankalp Life Care

    Ahmedabad (Gujarat) [India], April 20: Ahmedabad-based Sankalp Life Care, a leading manufacturer of nutraceuticals, and Mumbai-headquartered Vaishali Pharma, a leading manufacturer and exporter of pharma formulations, have come together to form a unique partnership that will help both companies grow faster.

    As per the agreement between the two companies, NSE-listed Vaishali Pharma will take over the entire domestic and international marketing of Sankalp Life Care’s portfolio of nutraceutical products.

    “This is a perfect partnership. Sankalp Life Care’s core strength is in manufacturing the best quality nutraceutical products, and Vaishali Pharma has a wide global presence in the Indian and multiple markets and specialises in marketing. The partnership will allow us to leverage Vaishali Pharma’s marketing reach and focus on our expertise. It is a win-win for both companies and we look forward to growing together and offering the highest-quality nutraceutical products to customers in India and around the world,” said Robin Goenka, Managing Director, Sankalp Life Care.

    “This agreement between Vaishali Pharma and Sankalp Life Care is the first-of-its-kind in the Indian pharma industry. Vaishali Pharma will handle the complete domestic and international marketing operations of Sankalp Life Care, and make Sankalp Life Care’s 100+ innovative products available in more than 40 countries. The unique agreement builds on the strengths of the two companies and will be mutually beneficial,” said Atul Vasani, Managing Director, Vaishali Pharma.

    Sankalp Life Care is a leading nutraceuticals company and has set up the 5th largest nutraceuticals facility in the country at Bavla, Ahmedabad. A range of tablets, capsules, powders, sachets, gummies, liquid and effervescent tablets, among other products are made at the zero-discharge facility, which is fully operational now, and has been designed as per standards defined by World Health Organisation. It is also designed as per USFDA standards and the company has already made an application for USFDA approval for the facility.

    Vaishali Pharma, which manufactures and exports pharma formulations in a wide spectrum of dosage forms & therapeutic segments, Active Pharmaceutical Ingredients (APIs), surgical products, nutraceutical, and oncology products, is one of the fastest-growing and most versatile companies in the industry. It has a strong presence in both the domestic and export markets and is currently a supplier to all leading Indian and multinational pharmaceutical companies. The company has been catering to semi-regulated and non-regulated markets across the globe.

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

    Related Posts

    Cordelia Cruises Crushes the Monsoon: Rs 585 Million Profit Blasts Past Last Year’s Loss

    October 9, 2026

    Rathi Steel And Power Limited Q2 FY27 Revenue at Over Rs 200 Cr, Growth of Over 30% YoY; Sales Volume Growth at ~28.86% YoY

    October 9, 2026

    PRISM 2026 connected industry, government & education institutions to shape India’s future-ready logistics workforce

    October 9, 2026

    Comments are closed.

    Recent Post
    • Cordelia Cruises Crushes the Monsoon: Rs 585 Million Profit Blasts Past Last Year’s Loss
    • Love Marriage and Relationship Problems: Guidance from Astrologer Sonu Sharma
    • British Indian MP Shivani Raja, in India on Parliamentary Visit, Congratulates Prime Minister Narendra Modi on 25 Years as Head of Government
    • Central India’s Biggest Industrial Expo: ‘Plast Pack 2026’ to Showcase the Technology of the Future
    • Rathi Steel And Power Limited Q2 FY27 Revenue at Over Rs 200 Cr, Growth of Over 30% YoY; Sales Volume Growth at ~28.86% YoY
    • Not 40 years, but people who shaped the journey, Khushboo Rai makes ‘Chapter 40’ memorable
    • PRISM 2026 connected industry, government & education institutions to shape India’s future-ready logistics workforce
    • PH1 Industries, Specialised Engineering Solutions Provider, Files DRHP with NSE Emerge

    Type above and press Enter to search. Press Esc to cancel.